Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
Clinical Characteristics and Outcomes of Influenza a (H3n2/H1n1) Infection in Hospitalized Patients: A Report From Iran 2022–2023 Cold Season Outbreak Publisher



Mr Salehi Mohammad REZA ; A Soleimany ARMAN ; A Shakoori ABBAS ; J Yavarian JILA ; Ma Arabzadeh Mohammad ALI ; Hb Azari Helya BOLOUKI ; M Edalatifard MARYAM ; A Sobati ABOLFAZL ; R Rahimnia RAMIN ; S Arefi SINA
Authors

Source: Iranian Journal of Medical Microbiology Published:2024


Abstract

Background and Aim: Influenza A subtypes H3N2 and H1N1 are currently circulating among humans and are the main cause of seasonal epidemics in the temperate regions. The specific clinical features of influenza H1N1 and H3N2 infections have not been well evaluated in Iranian patients. Materials and Methods: An observational study was conducted on influenza-confirmed patients in Imam Khomeini Hospital Complex, Tehran, Iran from October 2022 to March 2023. The specimens tested positive for influenza, using RT-PCR, were transported to the National Influenza Center (NIC) Laboratory for the typing identification. Different data, including demographics, comorbidities, length of hospitalization, outcomes, paraclinical features, and recent influenza vaccination, were collected. Results: A number of 165 hospitalized patients with influenza infection were included: 148 (89.70%) patients with H3N2 and 17 (10.30%) with H1N1 infections. Among the patients 55.20% were male. The median age was 49 years. The patients were symptomatic for an average of 8 days. The most common symptoms were dyspnea (60.6%), fever (58.8%), and productive cough (37.6%). The median oxygen saturation was significantly lower in the H3N2 group (91%–81.0, 96.0) than in the H1N1 group (95%–90.0, 97.5) (P=0.029). The ground glass opacity (GGO) was the most common (69.1%) pulmonary radiological pattern. Only one patient had received the influenza vaccine in the recent year. The mortality rate (19 patients: 11.55%) was associated with the cancer and liver diseases. Conclusion: Influenza A (H3N2 and H1N1) can be considered the outbreak cause in Iran in 2022–2023. The vaccination rate was very low and the mortality rate was high. Influenza vaccination is recommended to prevent death, especially in the patients with cancer. © 2024 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. Assessment of Influenza a (H1n1, H3n2) Oseltamivir Resistance During 2017-2019 in Iran, Iranian Journal of Microbiology (2022)
2. Potential of H1n1 Influenza a Virus As an Air Borne Pathogen to Induce Infectivity in Pancreas: A Mouse Model Study, Journal of Environmental Health Science and Engineering (2020)
3. Influenza Species and Subtypes Circulation Among Hospitalized Patients in Laleh Hospital During Two Influenza Seasonal (2016-2017 and 2017-2018) Using a Multiplex Real Time-Polymerase Chain Reaction, Infectious Disease Reports (2020)
Experts (# of related papers)
View all Related Experts
Nazanin Zahra Shafiei Jandaghi (5)
Jila Yavarian (5)
Other Related Docs
4. Prevalence of Influenza A(H1n1)Pdm09 Virus Resistant to Oseltamivir in Shiraz, Iran, During 2012 - 2013, Jundishapur Journal of Microbiology (2015)
5. Influenza Virus But Not Mers Coronavirus Circulation in Iran, 2013–2016: Comparison Between Pilgrims and General Population, Travel Medicine and Infectious Disease (2018)
6. Seasonal Influenza A/H3n2 Virus Infection and Il-1Β, Il-10, Il-17, and Il-28 Polymorphisms in Iranian Population, Journal of Medical Virology (2016)
7. Risk Factors Associated With Outcomes of Seasonal Influenza in Pregnant Women Referring to Healthcare Centers in Iran in 2015-2016, Archives of Clinical Infectious Diseases (2019)
8. Prevalence of Human Influenza Virus in Iran: Evidence From a Systematic Review and Meta-Analysis, Microbial Pathogenesis (2018)
9. Human Metapneumovirus and Influenza Viruses in Children With Severe Acute Respiratory Infections in Iran, Iranian Journal of Pediatrics (2018)
10. Antigenic Variation of the Haemagglutinin Gene of the Influenza a (H1n1) Pdm09 Virus Circulating in Shiraz, February-April 2013, Iranian Journal of Immunology (2015)
11. Trends in Surveillance Data of Influenza Virus in Tehran Before Decreasing Dispatch of Iranian Hajj Pilgrims to Mecca, Medical Journal of the Islamic Republic of Iran (2018)
12. Ha Antigenic Variation and Phylogenetic Analysis of Influenza B Virus in Shiraz, Iran, Acta Tropica (2024)
13. Spectrum of Respiratory Viruses Among Returning Iranian Pilgrims With Respiratory Symptoms During the Covid-19 Pandemic: A 2022 Study, Coronaviruses (2025)
14. Analysis of Amino Acid Changes in Ns Protein of Influenza A/(H3n2) Virus in Iranian Isolates, Future Virology (2015)
15. Prevalence of Influenza a Infection in the Middle-East: A Systematic Review and Meta-Analysis, Clinical Respiratory Journal (2018)
16. Surveillance of Endemic Coronaviruses During the Covid-19 Pandemic in Iran, 2021–2022, Influenza and other Respiratory Viruses (2023)
17. Effect of Haemophilus Influenzae Type B Vaccination on Nasopharyngeal Carriage Rate in Children, Tehran, 2019, BioMed Research International (2021)
18. A Review of Influenza Surveillance System in the Islamic Republic of Iran: History, Structures and Processes, Iranian Journal of Epidemiology (2019)
19. Estimation of Influenza and Severe Acute Respiratory Illness Incidence (Burden) in Three Provinces of the Islamic Republic of Iran, 2012 and 2013; [Estimation De L’Incidence (Charge) De La Grippe Et De L’Infection Respiratoire Aigue Severe En Republique Islamique D’Iran Pour 2012 Et 2013], Eastern Mediterranean Health Journal (2016)
20. Demographic, Clinical, and Virological Characteristics of Patients With a Laboratory-Confirmed Diagnosis of Influenza During Three Consecutive Seasons, 2015/2016–2017/18, in the Islamic Republic of Iran, Journal of Clinical Virology (2020)